Research and Development

By matching its know-how and expertise with the medical needs observed in the marketplace, Nobilon will develop its vaccine portfolio.

The Development of a Vaccine Portfolio

Nobilon’s research targets aim to develop a human vaccine portfolio around:

• Respiratory vaccines, such as Influenza vaccines
  
  
• Traveler vaccines, such as a vaccine against traveler’s diarrhea
  
  
• Vaccines against sexually transmitted diseases
  
  
• The development and production of monoclonal antibodies (MAB's) for selected disease areas